Post-IPO Equity - Alnylam Pharmaceuticals - Apr 8, 2019 Funding Round Profile - Cointime

Bitcoin $97,434.92 -0.09%
Ethereum $3,457.40 +3.47%
BNB $653.52 -0.13%
Optimism $2.22 +4.80%
Arbitrum $0.90 +7.69%
Solana $247.90 +0.22%
Polygon $0.58 +6.64%
Cosmos $8.48 -1.67%
Avalanche $43.89 +8.77%

Bitcoin $97,434.92 -0.09%
Ethereum $3,457.40 +3.47%
BNB $653.52 -0.13%
Optimism $2.22 +4.80%
Arbitrum $0.90 +7.69%
Solana $247.90 +0.22%
Polygon $0.58 +6.64%
Cosmos $8.48 -1.67%
Avalanche $43.89 +8.77%

Alnylam Pharmaceuticals

company

Funding Round

Post-IPO Equity

Money Raised

$ 800M

Propotion

-

Post Valuation

-

Current Round Investors

Investor Name	Invest Money	Lead Investor	Propotion
Regeneron	-	Yes	-	Detail

Historical Financing

Announced Date	Round	Money Raised	Investors
Jul 7, 2003	Private Equity（PE）	$ 24.60M	Merck,ARCH Venture Partners	Detail
Mar 28, 2011	Post-IPO Equity	$ 10M	Takeda	Detail